1 May 1999

Cellular Elongation Factor 1δ Is Modified in Cells Infected with Representative Alpha-, Beta-, or Gammaherpesviruses

ABSTRACT

Earlier reports (Y. Kawaguchi, R. Bruni, and B. Roizman, J. Virol. 71:1019–1024, 1997; Y. Kawaguchi, C. Van Sant, and B. Roizman, J. Virol. 72:1731–1736, 1998) showed that herpes simplex virus 1 (HSV-1) infection causes the hyperphosphorylation of translation elongation factor 1δ (EF-1δ) and that the modification of EF-1δ is the consequence of direct phosphorylation by a viral protein kinase encoded by the UL13 gene of HSV-1. The UL13 gene is conserved in members of all herpesvirus subfamilies. Here we report the following. (i) In various mammalian cells, accumulation of the hyperphosphorylated form of EF-1δ is observed after infection with alpha-, beta-, and gammaherpesviruses, including HSV-2, feline herpesvirus 1, pseudorabiesvirus, bovine herpesvirus 1, human cytomegalovirus (HCMV), and equine herpesvirus 2. (ii) In human lung fibroblast cells infected with recombinant HSV-1 lacking the UL13 gene, the hypophosphorylated form of EF-1δ is a minor species, whereas the amount of the hyperphosphorylated form of EF-1δ significantly increases in cells infected with the recombinant HSV-1 in which UL13 had been replaced by HCMV UL97, a homologue of UL13. These results indicate that the posttranslational modification of EF-1δ is conserved herpesvirus function and the UL13 homologues may be responsible for the universal modification of the translation factor.
The herpesviruses have been subdivided into three subfamilies based on molecular and biological properties (27). Although members of the three herpesvirus subfamilies exhibit a wide range of biological properties and the range of pathogenic manifestations (27), their genomes contain a significant number of conserved genes. These conserved genes include genes encoding glycoproteins (e.g., gB and gH), regulatory proteins (e.g., ICP27), and a large array of conserved enzymes involved in posttranslational modification of protein (e.g., protein kinases), DNA synthesis (e.g., DNA polymerase, helicase, and primase), and processing of proteins (e.g., protein kinase) (28). This conservation suggests that these gene products play an essential role in the life cycle of herpesviruses.
In an earlier study, we showed that infection of cells with herpes simplex virus 1 (HSV-1), a prototype of alphaherpesvirus, causes extensive hyperphosphorylation of translation elongation factor 1δ (EF-1δ) (11). In a subsequent study, we found that the gene product of HSV-1 responsible for EF-1δ hyperphosphorylation is a viral protein kinase encoded by the UL13 gene (13). This observation and the fact that the amino acid sequence that encodes UL13 protein kinase is conserved in members of all subfamilies of the family Herpesviridae led us to investigate whether EF-1δ is also posttranslationally modified in cells infected with representative members of all subfamilies of herpesviruses. In this report, we present evidence that this is in fact the case. In one instance, we have specifically related the modification of EF-1δ to the protein kinase encoded by UL97, the human cytomegalovirus (HCMV) homologue of the UL13 gene of HSV-1. Relevant to this report are the following observations.
(i) EF-1δ is a subunit of EF-1, a complex of proteins which mediate the elongation of polypeptide chains during translation of mRNA (16, 18, 26, 33). EF-1α transports aminoacyl tRNA for binding to ribosomes concurrent with the hydrolysis of GTP. EF-1δ is a component of the EF-1β–EF-1γ–EF-1δ complex which is responsible for GDP-GTP exchange on EF-1α, and numerous studies have ascribed to EF-1δ regulatory functions (16, 19, 26).
(ii) EF-1δ interacts with two viral proteins in cells infected with HSV-1. As reported elsewhere, EF-1δ interacts with ICP0, an α protein known primarily for its function as a promiscuous transactivator. Thus, ICP0 interacts physically in the yeast two-hybrid system with EF-1δ, and the domain of ICP0 interacting with EF-1δ affects translational efficiency in vitro (11). ICP0 is a multifunctional protein which interacts with and modulates many key cellular functions, including transcription (7, 10), translation (11), cell cycle regulation (12), and the protein degradation pathway (6). EF-1δ also interacts with and is hyperphosphorylated by the protein kinase encoded by the UL13 gene. The observation that two viral proteins interact with EF-1δ suggests that this protein plays an important role in the viral life cycle.
(iii) The UL13 gene was originally reported to contain motifs conserved in eukaryotic protein kinase (1, 30) and in subsequent studies was associated with the phosphorylation of itself, EF-1δ, and several viral proteins (e.g., ICP22, ICP0, and gE) (2, 13, 20, 22, 25). Recent evidence based on experiments on purified UL13 protein unambiguously demonstrated that it is a protein kinase (3). The UL13 protein is packaged into virion, and indeed, a protein kinase activity is associated with purified virions (2, 23). Experiments with genetically engineered viruses lacking the UL13 gene showed that the viral protein kinase affects the accumulation of ICP0 and a subset of γ proteins, suggesting that the kinase activity of UL13 may play a regulatory function (24).
(iv) The HCMV protein UL97 has homology to UL13 of HSV, so the protein was predicted to be a protein kinase (1). Interestingly, the UL97 protein phosphorylates ganciclovir, a nucleotide analog effective against HCMV infection, and therefore, the viral protein can act as a deoxynucleoside kinase (14, 31). Studies on recombinant HSV-1 in which the UL13 protein was replaced by its HCMV homologue showed that UL97 can substitute for the UL13 protein kinase (Fig.1), and only recently it has been shown to be a serine/threonine kinase that phosphorylates itself (8, 21). The results supported the hypothesis that UL97 is a protein kinase with the unusual property of being able to phosphorylate deoxynucleosides.
Fig. 1.
Fig. 1. Schematic diagram of the sequence arrangement of the HSV-1 genome showing the location of the UL13 gene. Line 1 shows a linear representation of the HSV-1(F) genome. The unique sequences are represented as the unique long (UL) and unique short (US) regions. The terminal repeats flanking the unique sequences are shown as open rectangles and their designations are given above. Line 2 shows an expanded section of the genome domain containing UL12, UL13, and UL14 open reading frames. The coding regions are represented by arrows. Line 3 shows R7356 with a deletion spanningHindIII (H) to BstEII (B) restriction endonuclease sites within the UL13 coding domain. Line 4 shows R4969, a recombinant virus in which the UL13 domain spanning HindIII to BstEII restriction endonuclease sites was replaced with the coding sequence of HCMV UL97 fused to the promoter of the UL26.5 gene (pUL26.5).
In this report we demonstrate that EF-1δ is commonly modified in cells infected with representative members of the alpha-, beta-, and gammaherpesvirus subfamilies and that this phenomenon is not unique to HSV-1-infected cells. We also present evidence that HCMV UL97 can mediate the modification of EF-1δ.
Vero and human lung fibroblast (HLF) cells were obtained from the American Type Culture Collection and Aviron (Mountain View, Calif.), respectively. Madin-Darby bovine kidney (MDBK) and cloned porcine kidney (CPK) cells were provided by H. Ohtsuka (The University of Tokyo). Crandell feline kidney (CRFK) cells were a gift from T. Mikami (The University of Tokyo). Fetal horse kidney (FHK) cells were isolated as described elsewhere (15) and used within seven passages of primary culture. The cell lines were grown in Dulbecco’s modified Eagle’s medium supplemented with either 10% fetal calf serum (HLF, MDBK, CPK, or CRFK cells) or 5% fetal calf serum (Vero cells).
The properties of the virus strains HSV-1(F), HSV-2(G), HCMV(Towne) and the genetically engineered recombinant viruses listed in Table1 have been described elsewhere (5, 9, 21, 22, 24, 25). Feline herpesvirus 1 [FHV-1(C7301)] (17) was provided by T. Mikami. Bovine herpesvirus 1 [BHV-1(LA)] and pseudorabies virus [PRV(Indiana)] were supplied by H. Ohtsuka. Japanese field isolates of equine herpesvirus 2 [EHV-2(87C26) and EHV-2(87C33)] were isolated with FHK cells as described elsewhere (15). gB regions of the genomes of the EHV-2 strains were amplified, cloned into pGEM-T vector (Promega), and sequenced. The sequences were completely identical to the published sequence of the EHV-2 gB (32).
Table 1.
Table 1. Genotype and phenotype of recombinant viruses used in this study
Virus Genotype or phenotypea
HSV-1(F) Wild-type
HSV-1(F)Δ305 ΔUL23/UL24
R4969 UL23/UL24(R), ΔUL13, HCMV UL97+
R4970 ΔUL23/UL24, ΔUL13, HCMV UL97+
R7355 ΔUL23/UL24, ΔUL13
R7356 ΔUL23/UL24(R), ΔUL13
R7358 ΔUL23/UL24, UL13(R)
a
Δ, deletion in gene; R, repair of gene. A superscript plus indicates that the gene is overexpressed.
The rabbit polyclonal antibody to EF-1δ was generated as described elsewhere (11). The electrophoretically separated proteins transferred to nitrocellulose sheets were reacted with the antibody to EF-1δ as described previously (11, 12).
The objective of the first series of experiments was to determine whether alphaherpesviruses other than HSV-1 also cause hyperphosphorylation of EF-1δ in infected cells. As reported previously, EF-1δ consists of two predominant forms, a hypophosphorylated form (apparent M r of 38,000) and a hyperphosphorylated form (apparent M r of 40,000) (11, 13, 19, 29). The polyclonal antibody used in this study can readily detect both forms of EF-1δ, and the pattern of bands of EF-1δ radiolabeled by 32Pi is exactly the same as that of EF-1δ detected by Western blotting (11, 13). To monitor changes in EF-1δ, Vero, CRFK, CPK and MDBK cells were harvested 24 h after mock infection or infection with HSV-2(G), FHV-1(C7301), PRV(Indiana), and BHV-1(LA), respectively, solubilized, electrophoretically separated in denaturing gels, electrophoretically transferred to nitrocellulose sheets, and reacted with the rabbit polyclonal antibody to EF-1δ. The results were as follows.
(i) In mock-infected Vero and CRFK cells, the two predominant bands migrating with M rs of 38,000 and 40,000, respectively, were detected (Fig. 2) as described previously (11, 13). The result that the polyclonal antibody raised against human EF-1δ-glutathioneS-transferase fusion protein detected EF-1δ in feline cells (Fig. 2) indicates that the epitopes to which the antibody is directed are conserved in nonhuman EF-1δ. In cells infected with HSV-2(G) or FHV-1(C7301), the amount of EF-1δ protein in slower-migrating bands was significantly increased (Fig. 2).
Fig. 2.
Fig. 2. Immunoblots of electrophoretically separated lysates from various mammalian cells mock infected or infected with alphaherpesviruses. The Vero, CRFK, CPK, and MDBK cells were infected with HSV-2, FHV-1, PRV, and BHV-1, respectively. The infected cells were harvested, solubilized, subjected to electrophoresis on sodium dodecyl sulfate–9% polyacrylamide gels, transferred to nitrocellulose sheets, and reacted with the antibody to EF-1δ. Molecular weights (in thousands) are shown to the left of each blot.
(ii) In mock-infected CPK and MDBK cells, the slow-migrating bands of EF-1δ protein observed in Vero and CRFK cells were barely detectable, whereas the slow-migrating bands of EF-1δ protein were prominent in cells infected with PRV(Indiana) or BHV-1(LA) (Fig. 2).
These results indicate that EF-1δ is commonly modified in cells infected with representative human and nonhuman alphaherpesviruses.
To address the question of whether beta- and gammaherpesviruses cause the modification in the migration of EF-1δ associated with hyperphosphorylation of the protein, we examined the electrophoretic mobility of EF-1δ accumulating in HLF or FHK cells infected with a human betaherpesvirus, HCMV, and an equine gammaherpesvirus, equine herpesvirus 2 (EHV-2), respectively. As shown in Fig.3, there was a dramatic increase in the abundance of the highly modified form of EF-1δ in cells infected with HCMV or EHV-2. In Fig. 3B, the amount of the hypophosphorylated form of EF-1δ also increased slightly after EHV-2 infection. However, the increase in hyperphosphorylated EF-1δ after EHV-2 infection is not due to a simple increase in the EF-1δ translation products but a consequence of modification of EF-1δ induced by EHV-2 infection since the slower-migrating band of EF-1δ was barely detectable when lysate from mock-infected cells containing a larger amount of hypophosphorylated form of EF-1δ than that from EHV-2-infected cells was subjected to Western blotting (data not shown). We infer from these results that the modification of EF-1δ is a conserved function in members of all subfamilies of Herpesviridae. The evidence that EF-1δ was modified in nonprimate cell lines such as feline, porcine, bovine, and equine cells (Fig. 2 and 3) indicates that the modification is not restricted to primate cells infected with human herpesviruses. Rather, it is conserved phenomena in a variety of species of mammalian cells infected with various animal herpesviruses.
Fig. 3.
Fig. 3. Immunoblots of electrophoretically separated lysates of HLF (A) and FHK (B) cells mock infected or infected with the indicated viruses. The infected cells were harvested, solubilized, subjected to electrophoresis on sodium dodecyl sulfate–9% polyacrylamide gels, transferred to nitrocellulose sheets, and reacted with the antibody to EF-1δ. Molecular weights (in thousands) are shown to the left of each blot.
The observation that herpesviruses of all subfamilies modify EF-1δ raised the possibility that the conserved UL13 homologues of other herpesviruses are involved in the modification of the protein. To test this hypothesis, we used the genetically engineered HSV-1 recombinants R4969 and R4970 (Fig. 1), in which the coding domains of UL13 were replaced by a chimeric gene capable of expressing HCMV UL97 (21). As reported elsewhere (13), the amounts of hypo- and hyperphosphorylated EF-1δ in cells infected with mutant viruses lacking the UL13 gene could not be differentiated from those of mock-infected cells. Therefore, if HCMV UL97 protein were involved in the modification of EF-1δ, the amount of the modified form of EF-1δ would increase after infection with R4969 and R4970. In this series of experiments, HLF cells were harvested 24 h after mock infection or infection with wild-type virus or mutant viruses, solubilized, electrophoretically separated in a denaturing gel, transferred to a nitrocellulose sheet, and reacted with the antibody to EF-1δ. The results were as follows.
(i) As reported previously (13), in mock-infected cells, the hypophosphorylated form of EF-1δ is dominant, whereas the amount of the hyperphosphorylated form of the protein increased after infection with wild-type viruses (Fig. 4, lanes 2 and 5). The electrophoretic pattern of EF-1δ extracted from mock-infected cells (lane 1) could not be differentiated from those observed for the protein extracted from cells infected with UL13 deletion viruses (lanes 3 and 6). Furthermore, the wild-type virus phenotype was restored in cells infected with the recombinant R7358, in which the UL13 sequence had been repaired (lane 8).
Fig. 4.
Fig. 4. Immunoblot of electrophoretically separated lysates of HLF cells mock infected or infected with the indicated viruses. The infected cells were harvested, solubilized, subjected to electrophoresis on a sodium dodecyl sulfate–9% polyacrylamide gel, transferred to a nitrocellulose sheet, and reacted with the antibody to EF-1δ. Molecular weights (in thousands) are shown to the left of the blot. ΔTK, thymidine kinase gene deleted; TKR, thymidine kinase gene repaired; UL97++, UL97 gene overexpressed.
(ii) In cells infected with UL13/UL97+ viruses (Fig. 4, lanes 4 and 7), the electrophoretic pattern of EF-1δ forms was clearly differentiated from those of cells infected with UL13 deletion mutants and mock-infected cells. The amount of the hyperphosphorylated form of EF-1δ significantly increased in cells infected with UL13/UL97+ viruses compared to that in mock-infected cells or cells infected with UL13 deletion mutant viruses, indicating that UL97 conferred on the recipient UL13 virus the capacity to modify EF-1δ. The pattern of EF-1δ in cells infected with UL13/UL97+ viruses was quite similar to that observed in cells infected with wild-type HCMV (Fig. 3A). These results indicate that the posttranslational modification of EF-1δ is mediated by HCMV UL97.
Phosphorylation of proteins by protein kinase is a major strategy employed by eukaryotic cells to regulate cellular function, including transcription, translation, protein degradation, etc. (4). Viruses use a similar strategy, both to regulate their own replicative processes and to modify cellular proteins to suite their needs. Our knowledge regarding the requirements of herpesviruses with respect to host biosynthetic processes depends in part on the identification of cellular proteins modified by viral protein kinases and on elucidation of the functions altered by the phosphorylation. We should note that the original observation that HSV-1 protein kinase phosphorylates EF-1δ should, in retrospect, have come as no surprise, since protein synthesis is the key to viral replication and yet the translation of mRNA seems immune to viral interference.
The hypothesis we have attempted to test stems from the observation that the cellular translation factor, EF-1δ is hyperphosphorylated by the HSV-1 UL13 protein kinase and the evidence that homologues of the UL13 gene are present in the genomes of members of all three subfamilies of herpesviruses (1, 30). Since protein kinases in general recognize specific substrates, the question arose whether other subfamilies of herpesviruses possess the ability to induce hyperphosphorylation of EF-1δ and whether homologues of UL13 mediate the modification of the translation factor. The salient features of our results are as follows.
(i) Alpha-, beta-, and gammaherpesviruses commonly induce the posttranslational modification of EF-1δ associated with hyperphosphorylation of the protein. Infection of various mammalian cells with alphaherpesviruses (HSV-2, FHV-1, PRV, and BHV-1), betaherpesvirus (HCMV), and gammaherpesvirus (EHV-2) induced accumulation of the slow-migrating form of EF-1δ in various mammalian cells susceptible to these viruses. These results indicate that the modification of EF-1δ in various species of mammalian cells is a conserved function expressed by all herpesviruses and by extension, that EF-1δ plays a crucial role in replication of the viruses.
(ii) The UL97 protein of HCMV mediates the posttranslational modification of EF-1δ. The electrophoretic profiles of EF-1δ from cells infected with the UL13/UL97+ viruses were different from those of cells infected with the parent UL13 viruses. Although the UL97 protein has long been thought to be a protein kinase because it has the motifs associated with protein kinases, the only available information of UL97 acting as a protein kinase is the evidence that it mediated the phosphorylation HSV-1 proteins when inserted into a HSV-1 genome (21) and that it phosphorylates itself (8). This report shows the first evidence that UL97 can also mediate the posttranslational modification that is involved in the phosphorylation of natural proteins except for UL97 itself. Although we have not demonstrated that UL97 directly phosphorylated EF-1δ, this is highly likely in light of the homology of UL97 and UL13 proteins. By extension, UL13 homologues of all herpesvirus subfamilies may be responsible for the posttranslational modification of EF-1δ.
The significant new contribution of this report is the observation that the modification of EF-1δ is a specific, conserved objective of herpesviruses belonging to all three subfamilies of herpesvirus family and not merely that of HSV-1. This observation eliminates the slim possibility that UL13 by chance retained the motif necessary to bind and phosphorylate EF-1δ. Our results indicate that EF-1δ is of universal importance in herpesvirus infection. Although the physiological role of the posttranslational modification of EF-1δ by herpesvirus infection remains to be determined, it is conceivable that the modification is beneficial to viral replication and is therefore associated with activation of higher level of protein synthesis. Further experiments to unveil the direct significance of the EF-1δ hyperphosphorylation are of interest and are currently under way.

Acknowledgments

We thank T. Mikami for providing CRFK cells and FHV-1(C7301) strain, and H. Ohtsuka for providing CPK and MDBK cells and PRV(Indiana) and BHV-1(LA) strains.
The work at Tokyo Medical and Dental University was supported in part by grants from the Ministry of Education, Science, Culture and Sport of Japan and the Japan Health Science Foundation. Y.K. was supported by a grant from the Ichiro Kanehara Foundation. The work at the University of Chicago was aided by grants from the National Cancer Institute (CA47451, CA71933, and CA78766) and the U.S. Public Health Service.

REFERENCES

1.
Chee M. S., Lawrence G. L., and Barrell B. G. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase.J. Gen. Virol. 70 1989 1151–1160
2.
Cunningham C., Davison A. J., Dolan A., Frame M. C., McGeoch D. J., Meredith D. M., Moss H. W. M., and Orr A. C. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase.J. Gen. Virol. 73 1992 303–311
3.
Daikoku T., Shibata S., Goshim F., Oshima S., Tsurumi T., Yamada H., Yamashita Y., and Nishiyama Y. Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2.Virology 235 1997 82–93
4.
Edelman A. M., Blumenthal D. K., and Krebs E. G. Protein serine/threonine kinases.Annu. Rev. Biochem. 56 1987 567–613
5.
Ejercito P. M., Kieff E. D., and Roizman B. Characterization of herpes simplex virus strains differing in their effect on social behavior of infected cells.J. Gen. Virol. 2 1968 357–364
6.
Everett R. D., Meredith M., Orr A., Cross A., Kathoria M., and Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein.EMBO J. 16 1997 566–577
7.
Everett R. D., Preston C. M., and Stow N. D. Functional and genetic analysis of the role of Vmw 110 in herpes simplex virus replication Herpesvirus transcription and its regulation. Wagner E. K. 1991 50 -76 CRC Press Boston, Mass
8.
He Z., He Y.-S., Kim Y., Chu L., Ohmstede C., Biron K. K., and Coen D. M. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines.J. Virol. 71 1997 405–411
9.
Hirai K., Maeda F., and Watanabe Y. Expression of early virus functions in human cytomegalovirus infected HEL cells: effect of ultraviolet light-irradiation of the virus.J. Gen. Virol. 38 1997 121–133
10.
Jordan R. and Schaffer P. A. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis.J. Virol. 71 1997 6850–6862
11.
Kawaguchi Y., Bruni R., and Roizman B. Interaction of herpes simplex virus 1 α regulatory protein ICP0 with elongation factor 1δ: ICP0 affects translational machinery.J. Virol. 71 1997 1019–1024
12.
Kawaguchi Y., Van Sant C., and Roizman B. Herpes simplex virus 1 α regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.J. Virol. 71 1997 7328–7336
13.
Kawaguchi Y., Van Sant C., and Roizman B. Eukaryotic elongation factor 1δ is hyperphosphorylated by the protein kinase encoded by the UL13 gene of herpes simplex virus 1.J. Virol. 72 1998 1731–1736
14.
Litter E., Stuart A. D., and Chee M. S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir.Nature 358 1992 160–162
15.
Matumura T., Sugiura T., Imagawa H., Fukunaga Y., and Kamada M. Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations.J. Vet. Med. Sci. 54 1992 207–211
16.
Merrick W. C. Mechanism and regulation of eukaryotic protein synthesis.Microbiol. Rev. 56 1992 291–315
17.
Mochizuki M., Konishi S., and Ogata M. Studies on cytopathogenic viruses from cats with respiratory infections. III. Isolation and certain properties of feline herpesviruses.Jpn. J. Vet. Sci. 39 1977 27–37
18.
Morales J., Cormier P., Mulner-Lorillon O., Poulhe R., and Belle R. Molecular cloning of a new guanine-nucleotide exchange protein, EF-1δ.Nucleic Acids Res. 20 1992 4091
19.
Mulner-Lorillon O., Minella O., Cormier P., Capony J.-P., Cavadore J.-C., Morales J., Poulhe R., and Belle R. Elongation factor EF-1δ, a new target for maturation-promoting factor in Xenopus oocytes.J. Biol. Chem. 269 1994 20201–20207
20.
Ng T. I., Ogle W. O., and Roizman B. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoprotein E and I.Virology 241 1998 37–48
21.
Ng T. I., Talarico C., Burnette T., Biron K., and Roizman B. Partial substitution of the functions of herpes simplex virus 1 UL13 gene by the human cytomegalovirus UL97 gene.Virology 225 1996 347–358
22.
Ogle W. O., Ng T. I., Carter K. L., and Roizman B. The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0.Virology 235 1997 406–413
23.
Overton H. A., McMillan D. J., Klavinskis L. S., Hope L., Ritchie A. J., and Wong-Kai-In P. Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion.Virology 190 1992 184–192
24.
Purves F. C., Ogle W. O., and Roizman B. Processing of the herpes simplex virus regulatory protein α22 mediated by the UL13 protein kinase determines the accumulation of a subset of α and γ mRNAs and proteins in infected cells.Proc. Natl. Acad. Sci. USA 90 1993 6701–6705
25.
Purves F. C. and Roizman B. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein α22.Proc. Natl. Acad. Sci. USA 89 1992 7310–7314
26.
Riis B., Rattan S. I. S., Clark B. F. C., and Merrick W. C. Eukaryotic protein elongation factors.Trends Biochem. Sci. 15 1990 420–424
27.
Roizman B. Herpesviridae Virology 3rd ed. Fields B. N., Knipe D. M., Howley P., Chanock R. M., Hirsch M. S., Melnick J. L., Monath T. P., and Roizman B. 1996 2221 -2230 Raven Press New York, N.Y
28.
Roizman B. and Sears A. E. The replication of herpes simplex viruses Virology 3rd ed. Fields B. N., Knipe D. M., Howley P., Chanock R. M., Hirsch M. S., Melnick J. L., Monath T. P., and Roizman B. 1996 2231 -2295 Raven Press New York, N.Y
29.
Sanders J., Brandsma M., Janssen G. M. C., Dijk J., and Moller W. Immunofluorescence studies of human fibroblasts demonstrate the presence of the complex of elongation factor-1βγδ in the endoplasmic reticulum.J. Cell Sci. 109 1996 1113–1117
30.
Smith R. F. and Smith T. F. Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus.J. Virol. 63 1989 450–455
31.
Sullivan V., Talarico C. L., Stanat S. C., Davis M., Coen D. M., and Biron K. K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.Nature 358 1992 162–164
32.
Telford E. A. R., Watson M. S., Aird H. C., Perry J., and Davision A. J. The DNA sequence of equine herpesvirus 2.J. Mol. Biol. 249 1995 520–528
33.
Van Damme H. T. F., Amons R., Karssies R., Timmers C. J., Janssen G. M. C., and Moller W. Elongation factor 1β of artemia: localization of functional sites and homology to elongation factor 1δ.Biochim. Biophys. Acta 1050 1990 241–247

Information & Contributors

Information

Published In

cover image Journal of Virology
Journal of Virology
Volume 73Number 51 May 1999
Pages: 4456 - 4460
PubMed: 10196346

History

Received: 16 November 1998
Accepted: 1 February 1999
Published online: 1 May 1999

Permissions

Request permissions for this article.

Contributors

Authors

Yasushi Kawaguchi
Department of Tumor Virology, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510,1 and
Tomio Matsumura
Epizootic Research Station, Equine Research Institute, Japan Racing Association, 1400-4, Shiba, Kokubunji-machi, Shimotsuga-gun, Tochigi 329-0412,2 Japan, and
Bernard Roizman
The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 606373
Kanji Hirai
Department of Tumor Virology, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510,1 and

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy